BioCorRx Inc. (BICX)
About BioCorRx Inc.
BIOCORRX INC NEW
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $797.2K
- Net income
- -$3.4M
- Total assets
- $2.1M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
BioCorRx Inc. (BICX) Stock Price
- Reported a net loss of $3.4M in FY2025.
- Trading 60% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review BioCorRx Inc..
Write a review
BioCorRx Inc.: frequently asked questions
Is BioCorRx Inc. an American company?
BioCorRx Inc. is a US-based company headquartered in Anaheim, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is BioCorRx Inc. headquartered?
BioCorRx Inc. is headquartered in Anaheim, California, United States.
Is BioCorRx Inc. publicly traded?
Yes — BioCorRx Inc. is a publicly traded company. Its stock trades under the ticker symbol BICX on the OTC.
What does BioCorRx Inc. do?
BioCorRx Inc. is an American Medical Devices company in the Health & Beauty sector.
